15 Sep

Four young researchers at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) were selected as fellows to the recently awarded five-year National Cancer Institute T32 Training Grant.


05 Aug

WASHINGTON (Aug. 5, 2020) — Genetic modifier HDAC6 was found to control tumor growth and halt metastasis in triple-negative breast cancer in vivo, according to a new study published in the top-tier journal Cancer Research by investigators at the George Washington University (GW) Cancer Center.


16 Jul

WASHINGTON (July 16, 2020) – The National Institutes of Health has awarded $3.6 million to ...


13 Jul

Knowing what cancer survivors value can help providers address gaps in care, improve the care experience, and increase behaviors and practices that support survivors’ ability to accept and manage their post-treatment care, according to focus group findings from researchers at the George...


29 Jun

The George Washington University (GW) School of Medicine and Health Sciences (SMHS) was recently awarded its first-ever National Institutes of Health T-32 research training grant from the National Cancer Institute (NCI) in support of the GW Cancer Biology Training Program. The $1.4 million, five...


05 May

A survey from the GW Cancer Center highlights the influence of supportive oncodermatology on patient quality of life


27 Mar

Findings published in Nanomaterials by a team at GW suggest that a combination of photothermal and epigenetic therapies may help to maximize the therapeutic benefits of melanoma, and possibly other tumors.


23 Mar

Researchers at the GW Cancer Center published a new knowledgebase and web portal, OncoMX, which will improve the exploration and research of cancer biomarkers in the context of related evidence.


07 Feb

A diagnosis of breast cancer is a scary moment in any person’s life, and going through treatment can be difficult on both the mind and the body, but at the George Washington University (GW) Cancer Center, the journey can be made a little easier thanks to support from current and former patients...


07 Feb

At the George Washington University (GW) Cancer Center, listening to the needs of the community is a vital responsibility. That’s why in the city that has among the highest percentages of individuals who identify as lesbian, gay, bisexual, transgender, queer, or intersex (LGBTQI), the GW Cancer...


07 Feb

Humans, by nature, are complex; they’re sometimes puzzles to be studied and solved. On paper, they can be divided and classified, neatly sifted into categories based on codes and diagnoses and demographics; this makes them more decipherable, but no less fascinating. For Lorens Helmchen, PhD, a...


07 Feb

HIV/AIDS currently affects more than 35 million people worldwide. Infection with HIV is associated with a wide range of long-term health complications, including the development of cancer, which is a major cause of death among individuals living with HIV. The AIDS and Cancer Specimen Resource (...


31 Jan

A new study published in the Journal of Cancer Survivorship by Mandi L. Pratt-Chapman, PhD, MA, associate center director for patient-centered initiatives and health equity at the George Washington University (GW) Cancer Center, and collaborators from the National Cancer Institute (NCI), the...


20 Aug

WASHINGTON (Aug. 16, 2019) — The extracellular regulated kinase (ERK) protein is an important mechanism behind platinum-resistance in platinum-resistant ovarian cancer, according to a study from a research team at the George Washington University (GW) Cancer Center. The study, which is the first...


07 Aug

An estimated 850,000 to 2.2 million people in the United States are living with Chronic Hepatitis B. A research team from the George Washington University (GW) received a $1.5 million grant from the Office of Minority Health of the U.S. Department of Health & Human Services (HHS) to reduce...